Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares at $26.41 ($920K) on 2026-10-09, disclosed to the SEC on 2026-10-13.
Scheduled sale ($920k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.41 | 11,881 | $314K | 34.1% |
| 2 | $25.35 | 9,181 | $233K | 25.3% |
| 3 | $26.07 | 2,700 | $70K | 7.7% |
| 4 | $25.50 | 11,881 | $303K | 32.9% |
| Total | $25.81 avg | 35,643 | $920K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |